Serotonin neurons located in the raphe nucleus of the hindbrain have crucial roles in regulating brain functions and have been implicated in various psychiatric disorders. Yet functional human serotonin neurons are not available for in vitro studies. Through manipulation of the WNT pathway, we demonstrate efficient differentiation of human pluripotent stem cells (hPSCs) to cells resembling central serotonin neurons, primarily those located in the rhombomeric segments 2-3 of the rostral raphe, which participate in high-order brain functions. The serotonin neurons express a series of molecules essential for serotonergic development, including tryptophan hydroxylase 2, exhibit typical electrophysiological properties and release serotonin in an activity-dependent manner. When treated with the FDA-approved drugs tramadol and escitalopram oxalate, they release or uptake serotonin in a dose-and time-dependent manner, suggesting the utility of these cells for the evaluation of drug candidates.
l e t t e r s
Serotonin neurons located in the raphe nucleus of the hindbrain have crucial roles in regulating brain functions and have been implicated in various psychiatric disorders. Yet functional human serotonin neurons are not available for in vitro studies. Through manipulation of the WNT pathway, we demonstrate efficient differentiation of human pluripotent stem cells (hPSCs) to cells resembling central serotonin neurons, primarily those located in the rhombomeric segments 2-3 of the rostral raphe, which participate in high-order brain functions. The serotonin neurons express a series of molecules essential for serotonergic development, including tryptophan hydroxylase 2, exhibit typical electrophysiological properties and release serotonin in an activity-dependent manner. When treated with the FDA-approved drugs tramadol and escitalopram oxalate, they release or uptake serotonin in a dose-and time-dependent manner, suggesting the utility of these cells for the evaluation of drug candidates.
Serotonin is involved in the regulation of mood, affection, cognition, aggression, satiety, sleep and other autonomic functions. Dysfunction of the serotonin system, especially misregulation of serotonin release or uptake, has been linked to schizophrenia, depression, bipolar disorder, anxiety, obsessive-compulsive disorder, chronic pain syndrome and eating disorders. The serotonin system is therefore a major target for the treatment of multiple psychiatric disorders 1 . Serotonin neurons are localized to the raphe nucleus of the hindbrain and arise during development from ventral hindbrain progenitors, which are specified by gradient concentrations of WNTs along the anterior-posterior axis; the higher the WNT concentration, the more caudal the cells will become 2 . Serotonin neurons are divided into two groups depending on their anatomical locations and projections, which are likely also influenced by WNT signaling. The rostral division is located just caudal to the isthmus and these neurons project and innervate virtually all areas of the brain. Among them, the progenitors located at rhombomeric (r) segments 2-3 are distinguished from r1 by expression of HOXA2 but not EN1, and generate median raphe serotonin neurons 3, 4 . The caudal division is situated in the myelencephalon, and these neurons send descending axons to the spinal cord 5 . Thus, serotonin neurons are essential for diverse neural functions despite their minority in the brain (~20,000 in the rat brain and ~300,000 in the human brain) 6, 7 .
To facilitate in vitro study of human central serotonin neurons and the development of therapeutics that target the serotonin system, we describe a strategy to differentiate hPSCs (both embryonic stem cells (hESCs) and induced pluripotent stem cells (iPSCs) to serotonin neurons by activating WNT and sonic hedgehog (SHH) signaling. The progenitors subsequently differentiate into a highly enriched population of cells that express key serotonin markers, including serotonin, TPH2, GATA3, GATA2, PET1, LMX1B, SERT, AADC and VMAT2. First, we differentiated human PSCs to hindbrain neural stem cells (NSCs) in a chemically defined medium containing transforming growth factor (TGF)-β inhibitor SB431542, BMP inhibitor DMH1 and GSK3-β inhibitor CHIR99021 (SDC medium) (Fig. 1a) . After 1 week in SDC medium, PSC markers OCT4 and NANOG were downregulated, and NSC markers SOX1, PAX6 and N-Cadherin were upregulated. No obvious expression of endoderm markers (EOMES and SOX17), mesoderm marker (T, Brachyury) or trophoblast marker (CDX2) was detected by Q-PCR (Supplementary Fig. 1a ). Immunostaining and flow cytometry analysis confirmed that most of the cells expressed SOX1 and SOX2 but not OCT4 (Supplementary Fig. 1b-d) , suggesting an NSC identity.
The hindbrain is divided into rostral regions (r1-3) and caudal regions (r5-8) by the r4 region, which expresses HOXB1. The r1 region is distinguished from the r2-3 regions by expression of HOXA2, with r1 being HOXA2-and r2-3 being HOXA2 + (refs. 5,8) (Fig. 1b) . We and others have shown that WNT activation by CHIR99021 specifies caudal neural progenitors in a dose-dependent manner [9] [10] [11] [12] . Indeed, when we increased the concentration of CHIR99021 to >1.0 µM, most of the cells exhibited hindbrain or spinal cord identities, indicated by the downregulation of forebrain and midbrain markers (FOXG1, EMX1, OTX2, NKX2.1, SIX3, EN1, LMX1A, LMX1B, SIM1 and LIM1) and upregulation of hindbrain and spinal cord markers (GBX2, KROX20,  HOXA1, HOXA2, HOXA3, HOXA4, HOXB1, HOXB2, HOXB3 and HOXB4) (Fig. 1c) . Cells expressing forebrain and/or midbrain markers (FOXG1, OTX2, EN1) gradually decreased, and those expressing hindbrain and spinal cord markers (HOXA2, HOXB1, HOXB4) gradually increased with increasing concentrations of CHIR99021 (Fig. 1d,e) . In cultures treated with 1.4 µM CHIR99021, most of the cells expressed HOXA2 but not HOXB1; at the same time, they were negative for HOXA3, a marker for the caudal hindbrain and spinal cord (Fig. 1b,e and Supplementary Fig. 1e ). HOXA2-expressing cells decreased with l e t t e r s lower concentrations of CHIR99021 (<1.4 µM), whereas HOXB1-and HOXB4-expressing cells increased with higher concentrations of CHIR99021 (>1.4 µM). These data indicate that rostral (r2-3) hindbrain NSCs are efficiently specified by 1.4 µM CHIR99021.
Next we sought to specify the rostral (r2-3) hindbrain NSCs into serotonin neuron progenitors. Serotonin neurons arise from progenitors in the ventral hindbrain that express NKX2.2 and NKX6.1 but not OLIG2 (ref. 13 and Fig. 2a) . We treated the differentiation cultures with SHH starting with week 2. As SHH concentrations increased, the expression of dorsal hindbrain markers (such as PAX3, PAX7 and IRX3) decreased; whereas the expression of ventral hindbrain markers (such as NKX6.1 and NKX2.2) increased ( Fig. 2b-d) . With a high concentration of SHH (1,000 ng/ml) for 1 week, the cells retained the neural progenitor and hindbrain identity, as indicated by the expression of Ki67, NESTIN, SOX1 and SOX2 (Fig. 2e-g and Supplementary Fig. 2a) . However, the majority of the cells were NKX2.2 + (89.8 ± 2.1%) and NKX6.1 + (90.0 ± 1.6%), whereas <5% of cells were OLIG2 + (Fig. 2h-k) . During serotonin neuron specification, NKX2.2 cooperates with MASH1 and GATA2 (GATA binding protein 2, for rostral serotonin neurons) or GATA3 (for caudal serotonin neurons) 1, 14 . In the culture, a substantial number of cells were MASH1 + (44.9 ± 7.0%) and GATA2 + (85.6 ± 3.4%), whereas only a few cells expressed GATA3 (8.3 ± 1.9%) (Fig. 2f,g,m) , suggesting that the cells were primarily rostral serotonin neuron progenitors.
FOXA2 is another transcription factor critical for the serotonergic fate, and is repressed by PHOX2B at r2-3 and r5-8 regions 1, 15 . After 2 weeks of differentiation and 1 week of treatment with SHH, few FOXA2 + cells were found, whereas 30% of the cells retained PHOX2B (30.6 ± 5.0%) (Fig. 2l,m) . This result suggests that additional signals are necessary to generate the serotonergic fate. As SHH cooperates with FGF4 (fibroblast growth factor 4) to promote the serotonergic program 16 , we applied FGF4 together with SHH for 1 week at the start of the second week of differentiation. A substantial increase in OLIG2 + cells was observed ( Supplementary Fig. 2b,c) , suggesting that FGF4 interferes with the ventralization of the hindbrain progenitors at this stage. Notably, when FGF4 was applied 1 week after cells were ventralized by SHH (after 3 weeks of differentiation), more cells turned on the expression of FOXA2 (72.4 ± 4.1%) and turned down the expression of PHOX2B (5.5 ± 1.1%), with a subsequent enriched TPH2 (tryptophan hydroxylase 2)-positive population after neuronal differentiation (Fig. 2n,o) . These data suggest that FGF4 facilitates the serotonergic program of the ventral hindbrain progenitors.
To assess the differentiation potential of the progenitors, we seeded them as single cells and cultured them in neural differentiation medium (NDM) without morphogens. Four weeks later, most of the cells became Tuj1 + neurons (>80%), whereas a small portion of the cells were GFAP + astrocytes (<15%) and Ki67 + dividing cells (<1%) (Fig. 3a,b) . Among the neurons, >60% were serotonin + , ~20% were TH + neurons and ~15% were GABA + neurons (Fig. 3c,d) . Most of the neurons also expressed markers for central serotonin neurons TPH2, GATA2 and VMAT2 (vesicular monoamine transporter 2). GATA3 was also turned on ( Fig. 3e) . Double-staining for serotonin and TPH2, serotonin and AADC (aromatic L-amino acid decarboxylase), and TPH2 and GATA3 (Fig. 3f) further indicated that the serotonin + neurons were central serotonergic neurons. Q-PCR and western blot analysis showed upregulation of other markers for serotonin neurons, including FEV (fifth Ewing variant, the human ortholog of mouse Pet-1), SERT (the serotonin transporter) and LMX1b (LIM homeobox transcription (Fig. 3g,h) . No serotonin neurons were found in cultures not treated with SHH and FGF4 (Supplementary Fig. 3a,b) . The efficient generation of serotonin neurons was reproduced in human ESCs (H9 line) and iPSCs (lines GM14 and GM15) (Fig. 3b,d) .
To assess functional maturation, we used electrophysiological whole-cell recording at 6 weeks in culture (Fig. 4a) . In the 15 neurons tested, the mean cell capacitance (Cap) and input resistance (R in ) was 25.0 ± 1.8 pF and 622.6 ± 27.8 MΩ, respectively. Inward Na + and outward K + currents were observed in these cells by voltage steps from −50 mV to +50 mV (Supplementary Fig. 4a ), implying the potentiation of action potentials. Indeed, injection of currents from −40 pA to +100 pA firmly triggered action potentials ( Supplementary  Fig. 4b ). Injected currents as low as +10 pA induced action potentials of a frequency positively correlated to the size of injected currents (Supplementary Fig. 4c ). In ~80% (12 of 15) of recorded neurons, excitatory (downward) and inhibitory (upward) postsynaptic spontaneous synaptic currents were observed, indicating formation of a functional synaptic network with surrounding neurons (Supplementary Fig. 4d ). Around 60% (9 of 15) of recorded neurons displayed a low rate (2.9 ± 0.2 Hz) of spontaneous action potential spikes with a slow, subthreshold oscillatory potential (-30 mV, Fig. 4b ), large action potential (65.3 ± 1.0 mV) and after hyperpolarization (−14.3 ± 0.6 mV), and long after hyperpolarization duration (87.4 ± 5.3 ms) (Fig. 4c) , which are characteristic features of serotonin neurons 17, 18 .
Next, we studied serotonin release and uptake with high-performance liquid chromatography coupled to ultra-performance liquid chromatography-electrospray ionization-tandem mass spectrometry (UPLC-ESI-MS/MS). Serotonin release increased over time, reaching a plateau at 3-4 weeks of neuronal differentiation. More serotonin was released from the higher cell-density group (Fig. 4d) . Stimulation of the cultures with high potassium (K + ), which depolarizes neurons, significantly increased serotonin release (P < 0.05) (Fig. 4e) , confirming serotonergic identity and the capacity of the cells to release serotonin in response to stimuli.
To determine whether the human serotonergic neuron culture could be used to validate serotonin releasers or selective serotonin reuptake inhibitors, we tested the effects of two US Food and Drug Administration (FDA)-approved drugs-tramadol (Ultram, ConZip, Ryzolt), a mu opiate agonist, inhibitor of monoamine (including serotonin) reuptake and serotonin releaser that is used to treat pain [19] [20] [21] and escitalopram oxalate (Lexapro; EO), a selective serotonin reuptake inhibitor used for treatment of major depressive disorder and generalized anxiety disorder 22 -on neurons cultured in NDM for 4 weeks. After 1 h exposure to tramadol, serotonin release increased in a dosedependent manner from neurons derived from both H9 ESCs and GM15 iPSCs (Fig. 4f) . Similarly, after EO treatment, serotonin release reached the peak level at the dosage of 100 nM EO and stayed at the peak level at higher dosages of EO (Fig. 4g) . When neurons were treated with either 100 µM tramadol or EO for different time periods, l e t t e r s serotonin release increased in a time-dependent manner as compared to the DMSO solvent control (Fig. 4h,i) . We have developed a chemically defined system to induce hPSCs to ventral hindbrain progenitors mainly at r2-3 segments, which further differentiate to enriched populations of serotonin neurons. Differentiation of serotonin neurons has been attempted using mouse, monkey and human ESCs. The mouse studies used FGFs (FGF2, FGF4 and/or FGF8) [23] [24] [25] as did the monkey studies (FGF2 and/or FGF4) 26, 27 . The only report of serotonin neuron differentiation from human ESCs used FGF1, FGF2, retinoic acid and the efficiency of producing serotonin-expressing cells was very low 28 . Although these papers all showed generation of serotonin-expressing cells, they did not demonstrate that the cells were functional and released serotonin (Supplementary Table 1) . It is now clear that FGFs are not effective in patterning human or nonhuman-primate ESCs to mid-or hindbrain progenitors 12, 29 . In fact, early application of FGF4 interferes with the specification of serotonin progenitors, as we show here.
Human PSCs, when cultured in the absence of morphogens 30 or in the presence of BMP and TGFβ inhibitors 31 , differentiate primarily to neural progenitors with forebrain identity. Thus, morphogens that promote caudalization, including WNTs and retinoic acid, are necessary. WNTs in particular are critical in patterning mid-and hindbrain identities in vivo 32 and in vitro [10] [11] [12] . By fine-tuning the concentrations of CHIR99021, we specified not only mid-and hindbrain progenitors but also different subpopulations of hindbrain progenitors. At 1.4 µM of CHIR99021, we obtained an enriched population of r2-3 hindbrain progenitors. Lower CHIR99021 concentrations produced forebrain and midbrain progenitors, whereas higher concentrations led to posterior hindbrain or spinal cord cells. These results suggest that it should be possible to specify most neuronal subtypes in the brain.
A neural progenitor identity is defined by its dorsal-ventral as well as anterior-posterior location in the developing brain. To generate serotonin neurons, we ventralized the hindbrain neural progenitors with SHH, as indicated by their expression of NKX6.1 and NKX2.2. Efficient specification of a ventral transcription factor NKX2.2 in the hindbrain progenitors by SHH is critical, as NKX2.2 at the r2-3 region regulates the timing of PHOX2B and FOXA2 expression, which in turn influences the progenitor identity. FOXA2 is a floor plate transcription factor and PHOX2B is a proneural factor for motor neuron generation 29, 33 . In the mouse embryonic brain, PHOX2B initially represses the expression of FOXA2 up to embryonic day (E)10.5. After that, FOXA2 represses PHOX2B to switch progenitors to the serotonergic fate 1 . It is by regulating the temporal switch between the expression of PHOX2B and FOXA2 by SHH in our hindbrain progenitors that we could generate highly enriched, subtypespecific ventral hindbrain progenitors with serotonergic potential.
The ventral hindbrain progenitors have the potential to become serotonin neurons but did not appear to give rise to serotonin neurons in our chemically defined system. During neural development, FGFs in the isthmus area contribute to specifying neuronal types with different transmitter phenotypes. FGF8 is important for midbrain dopamine neurons and FGF4 for hindbrain serotonergic neurons 16 . npg l e t t e r s Indeed, we found that FGF4 significantly enhances the differentiation of the ventral hindbrain progenitors to serotonin neurons. This is very similar to the effect of FGF8 in promoting dopamine neuron differentiation from ventral midbrain progenitors 12 . The FGF4 effect is time-dependent, working after specification of ventral hindbrain progenitors. Earlier FGF4 application interferes with the specification of the NKX2.2 + and NKX6.1 + hindbrain progenitors, possibly by repressing SHH signaling 34 . Our finding may seem to contradict the observation that in rat explant cultures FGF4 must be added before SHH and FGF8 to generate serotonin neurons 16 . This may represent a species difference. However, the hindbrain tissue explant was exposed to SHH in the developing embryo before isolation 16 , which would be consistent with our observation. Serotonin neurons exert diverse functions depending on their locations and targets. Those located in the anterior raphe project to almost the entire brain and regulate a multitude of central actions, including feeding, sleep and mood. Because we restricted the progenitors to the anterior ventral hindbrain fate, the differentiated serotonin neurons resemble those in the anterior raphe. They exhibited characteristic oscillatory action potential spikes and released serotonin under nonstimulated conditions, similar to what serotonin neurons do in the brain. Because they can be produced in large quantities, they can be used to validate drugs that affect serotonin release or uptake as an alternative to current assays based on dialysis measurement of serotonin in the dorsal raphe nucleus, prefrontal cortex and nucleus accumbens [35] [36] [37] .
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